Prevention of Recurrent Infections Caused by Community Acquired Staphylococcus Aureus (CA-SA) in Children
NCT00901316 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 987
Last updated 2016-11-07
Summary
The primary purpose of this study is to determine if adding bleach baths to routine ways for prevention of Staph infections is helpful. The amount added is a very weak amount. This would provide a relatively inexpensive method to help prevent recurrent skin infections caused by the Staph germ. The investigators will also be studying how often Staphylococcus aureus lives in the nose, throat, and groin area.
Conditions
- Community-Acquired Staphylococcus Aureus
Interventions
- PROCEDURE
-
Routine Measures Group
Cultures will be obtained from the anterior nares of the nose, the throat and the groin using separate culturette swabs. S. aureus isolates will be identified and antibiotic susceptibility determined. Isolates will subsequently undergo testing for susceptibility to methicillin to determine if the isolate is an MSSA or MRSA strain. All patients and parents will be instructed orally and provided written instructions about routine measures employed for the prevention of S. aureus skin infections. Please see supplemental material from the publication Randomized Trial of "Bleach Baths" plus Routine Hygienic Measures vs Routine Hygienic Measures Alone for Prevention of Recurrent Infections Clinical Infectious Diseases 2014;58:679-682 for the details regarding routine measures.
- PROCEDURE
-
Bleach Bath Group (Bleach plus routine measures)
Cultures will be obtained from the anterior nares of the nose, the throat and the groin using culturette swabs. S. aureus isolates will be identified and antibiotic susceptibility determined. Isolates will subsequently undergo testing for susceptibility to methicillin to determine if the isolate is an MSSA or MRSA strain. Patients and parents will be instructed orally and provided written instructions about routine measures employed for the prevention of S. aureus skin infections. Patients will be given further oral and written instructions regarding clorox baths. Please see supplemental material from the publication Randomized Trial of "Bleach Baths" plus Routine Hygienic Measures vs Routine Hygienic Measures Alone for Prevention of Recurrent Infections Clinical Infectious Diseases 2014;58:679-682 for the details regarding instructions for bleach baths.
Sponsors & Collaborators
-
Baylor College of Medicine
lead OTHER
Principal Investigators
-
Sheldon L Kaplan, MD · Baylor College of Medicine
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 3 Months
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-06-30
- Primary Completion
- 2012-01-31
- Completion
- 2013-01-31
Countries
- United States
Study Locations
More Related Trials
-
Treating Parents to Reduce NICU Transmission of Staphylococcus Aureus Trial
NCT02223520 ·Status: COMPLETED ·Phase: NA
-
Feasibility and Safety Study of Parent-to-Child Nasal Microbiota Transplant
NCT05695196 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Staphylococcus Aureus Decolonization Study
NCT00731783 ·Status: COMPLETED ·Phase: NA
-
Methicillin-resistant Staphylococcus Aureus (MRSA) Skin and Soft Tissue Infection (SSTI) Prevention in Military Trainees
NCT01105767 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Decolonization Rate and Acceptance of a Complete Nasal Decolonization Kit With Povidone Iodine for MRSA Patients
NCT05696132 ·Status: TERMINATED ·Phase: PHASE2
-
Early Infectious Disease Consultations in Staphylococcus Aureus Bacteremia
NCT00622882 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of an Algorithm for Identifying Persistent Nasal Staphylococcus Aureus Carriage in a Cohort of Healthy Volunteers and Patients Regularly Monitored at the CHU of Saint-Etienne
NCT02557568 ·Status: COMPLETED ·Phase: NA
-
Whole Body Washing With Chlorhexidine for the Eradication of MRSA
NCT00266448 ·Status: COMPLETED ·Phase: PHASE2
-
Probability of Target Attainment With Standard Intermittent Bolus Administration of Cefazolin in Patients With Complicated Infections Caused by Staphylococcus Aureus
NCT04503252 ·Status: COMPLETED
-
Colonization, Infection, and Molecular Typing of Methicillin-Resistant Staphylococcus Aureus (MRSA) in Children.
NCT00254527 ·Status: COMPLETED
-
STaph Aureus Resistance-Treat Early and Repeat (STAR-TER)
NCT03489629 ·Status: COMPLETED ·Phase: PHASE2
-
Individualized vs. Household MRSA Decolonization
NCT01814371 ·Status: COMPLETED ·Phase: NA
-
Human Immunity Against Staphylococcus Aureus Skin Infection
NCT02262819 ·Status: COMPLETED ·Phase: PHASE1
-
Host Factors in Invasive and Recurrent Staphylococcus Aureus Infection
NCT00911430 ·Status: TERMINATED
-
Staphylococcus Aureus Carrier Status in Breastfeeding Mothers and Infants and the Risk of Lactation Mastitis
NCT00620984 ·Status: COMPLETED
-
S. Aureus Screening and Decolonization
NCT02182115 ·Status: COMPLETED ·Phase: PHASE4
-
Staphylococcus Aureus Nasal Carriage
NCT02796690 ·Status: COMPLETED
-
Clearance of Nasal Staphylococcus Aureus With Triple Antibiotic Ointment
NCT00997139 ·Status: COMPLETED ·Phase: NA
-
Study of the Nasal Decolonisation of Staphylococcus Aureus (SA) and the Safety and Tolerability of XF-73 Nasal Gel in Healthy Subjects
NCT02282605 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Prospective Trial of Nasal Mupirocin, Hexachlorophene Body Wash, and Systemic Antibiotics for Prevention of Recurrent Methicillin Resistant Staphylococcus Aureus Infections
NCT01049438 ·Status: COMPLETED ·Phase: NA
-
Virulence Determinants in S Aureus Bacteremia
NCT00319826 ·Status: COMPLETED
-
Staph Household Intervention for Eradication (SHINE)
NCT02572791 ·Status: COMPLETED ·Phase: PHASE4
-
Chart Review of Outcome of Treatment for S. Aureus Bacteremia
NCT00304902 ·Status: COMPLETED
-
A Study to Evaluate the Safety and Efficacy of 3% LTX-109 for Nasal Decolonisation of Staphylococcus
NCT04767321 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of Staphylococcus Aureus Colonization of the Posterior Nasal Cavity in Patients Undergoing Otorhinolaryngologic Surgery
NCT02595112 ·Status: COMPLETED ·Phase: NA